Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD : For prime time not yet: Need impact and certainty.
作者信息
Schelbert Heinrich
机构信息
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, 650 Charles E Young Drive South, Los Angeles, CA, 90095, USA.
出版信息
J Nucl Cardiol. 2018 Feb;25(1):153-156. doi: 10.1007/s12350-016-0423-5. Epub 2017 Apr 10.
PMID:28397180
Abstract
摘要
Zotero 插件